Bangalore, April 9, 2008: Dabur OncQuest, an Oncology medical testing company and part of one of India’s oldest pharma and OTC drug company Dabur, has entered Nepal.
It has started operations in Kathmandu as the location for a collection center, through which patients in Nepal will now have access to all the technically advanced and cost effective diagnostic tests being offered by Dabur OncQuest in India.
Mr. Aditya Burman, General Manager, Dabur Pharma said, “OncQuest has excelled and pioneered many cost-effective cancer tests, with its in-house research and development laboratory; IRMA being one of them. Cancer patients in Nepal have to bear high costs of the tests despite it being offered by OncQuest in India at almost half of the US prices. Understanding the high cost and the need gap of tests available in Nepal we decided to reach out to the patients by extending our advanced and economical services. We have always believed and stood by the fact that “World Class Patient Management is the prime need for our business operations.“
Vivek Trikha, Head Diagnostics, Dabur OncQuest said, “Foreseeing huge potential in Nepal we did a pilot run and diagnosed samples of over 200 patients leading to business of more than 1.5 million. With the successful and much appreciated completion of the project, we have won the confidence of doctors and patients. We are pleased to announce our full – fledged services in Nepal through our first commercial collection center in Kathmandu. We are planning further to develop two more collection centers one being at Bharatpur and other at Chitwann.”
| 
Comment on this article
